Notice

Permit for use of BLUEVAC-3 bluetongue serotype 3 vaccine in the UK

Defra’s Secretary of State has permitted the use of this bluetongue serotype 3 (BTV-3) vaccine within the United Kingdom, subject to licence.

• From: Department for Environment, Food & Rural Affairs and Baroness Hayman of Ullock
• Published: 4 September 2024

Documents

Permit for use of BLUEVAC-3 bluetongue serotype 3 vaccine in the UK

PDF, 90.7 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Defra’s Secretary of State has permitted the use of 3 bluetongue serotype 3 (BTV-3) vaccines within the United Kingdom, subject to licence. You can read about and apply for licences on Bluetongue serotype 3 (BTV-3) vaccination.

Unlike the authorised vaccines for other BTV serotypes, the BTV-3 vaccines claim to reduce viraemia rather than prevent it. This means they will not prevent your animals from being infected or infectious, but (depending on the vaccine) their claims include reduction or prevention of clinical signed experienced or mortality.

For this reason, all movement controls and trade restrictions still apply to vaccinated animals.

Contact your private veterinarian if you want to use any of the available BTV-3 vaccines.

Published 4 September 2024